Research for predictors of the efficacy of add-on therapy for overactive bladder symptoms in men treated for lower urinary tract symptoms

Research for predictors of the efficacy of add-on therapy for overactive bladder symptoms in men treated for lower urinary tract symptoms - Research for predictors of the efficacy of add-on therapy for overactive bladder symptoms in men treated for lower urinary tract symptoms

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036799

Enrollment

100

Registered

2019-07-01

Start date

2019-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia Overactive Bladder

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: The patient with lower urinary tract symptoms and benigh prostatic hyperplasia (Prostate volume is over 20mL.)

Exclusion criteria

Exclusion criteria: We excluded the patient had urinary tract infection, suspected urinary tract malignancy, treatment history of urinary tract malignancy and urinary tract surgery history.

Design outcomes

Primary

Measure	Time frame
The factors associated with residual overactive bladder symptoms eight weeks after the start of add-on therapy in male lower urinary tract symptoms patient	—

Countries

Japan

Contacts

Public ContactKanako Matsuoka

Fukushima Medical University School of Medicine Department of Urology

kanaco@fmu.ac.jp024-547-1316

Outcome results